Last reviewed · How we verify

NCT05019196

fMRI Study of Functional Reorganization in Glioma Patients

Status unknown Last updated 24 August 2021
What this trial tests

trial testing GE 3.0T MRI in Glioma in 100 participants. Status unknown.

Timeline
1 September 2021
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorFirst Affiliated Hospital Xi'an Jiaotong University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date1 September 2021
Primary completion31 December 2022
Estimated completion31 December 2022

Drugs / interventions tested

Conditions studied

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Who can join

Eligibility, any sex, with Glioma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Glioma is an invasive growth, easy to relapse, poor prognosis, great harm to human and society. Studies have shown that gliomas can cause the dynamic reorganization of brain functional areas, affecting the accuracy of surgical resection and the evaluation of long-term efficacy. While, it is difficult to monitor the functional reorganization of glioma in existing studies. The development trend can not effectively predict the outcome of tumor anaplasia and the compensation of brain function, which restricts the accurate tumor resection. In the early stage of this study, functional connectivity analysis was carried out of gliomas in the motor region and showed that the damage of motor functional connectivity on the opposite side of the lesion occurred earlier than that on the same side, suggesting that there may be some rules of how the disease caused functional reorganization. After stroke, the language and motor function will undergo plasticity, causing the functional areas to slowly repair the damaged function. Contrast to stroke, low-grade glioma grows slower, which gives brain more time to adapt to the damage caused by tumor growth, it may cause more functional reorganization. Professor Hugues Duffau's research showed that it is brain plasticity that can effectively explain patients with low-grade gliomas, even in language and motor areas, did not appear obvious dysfunction. Our previous research found there were significant differences in motor functional connectivity between the two hemispheres of the patients between the plasma tumor group and healthy controls. In addition, in the tumor group, the damage of motor connection on the contralateral side of the lesion occurred before on the ipsilateral side. These results suggest that brain function has been remodeled in patients with brain tumors who have not yet exhibited motor impairment. We presume there may be a certain pattern of brain function reorganization caused by low-grade glioma. This study take patients with brain glioma as the research object and adopt a multi-time point experimental design, combining with cortical electrical stimulation and multimodal magnetic resonance imaging data before and after operation, intending to observe the dynamic changes of language and motor function networks.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Predicting isocitrate dehydrogenase status in glioma using hierarchical attention-based deep 3D multiple instance learning.
    Xie Q, Sun Y, Liang Y, Shang Y, et al · · 2025 · PMID 41487582 · DOI 10.3389/fonc.2025.1665690

Verify or expand the search:

Other recruiting trials for Glioma

Currently open trials in the same condition.

Other First Affiliated Hospital Xi'an Jiaotong University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05019196.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing